157 related articles for article (PubMed ID: 19505548)
1. Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting.
Morille M; Passirani C; Letrou-Bonneval E; Benoit JP; Pitard B
Int J Pharm; 2009 Sep; 379(2):293-300. PubMed ID: 19505548
[TBL] [Abstract][Full Text] [Related]
2. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
Morille M; Montier T; Legras P; Carmoy N; Brodin P; Pitard B; Benoît JP; Passirani C
Biomaterials; 2010 Jan; 31(2):321-9. PubMed ID: 19800113
[TBL] [Abstract][Full Text] [Related]
3. Tumor transfection after systemic injection of DNA lipid nanocapsules.
Morille M; Passirani C; Dufort S; Bastiat G; Pitard B; Coll JL; Benoit JP
Biomaterials; 2011 Mar; 32(9):2327-33. PubMed ID: 21185595
[TBL] [Abstract][Full Text] [Related]
4. Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes.
Zhang XQ; Wang XL; Zhang PC; Liu ZL; Zhuo RX; Mao HQ; Leong KW
J Control Release; 2005 Feb; 102(3):749-63. PubMed ID: 15681095
[TBL] [Abstract][Full Text] [Related]
5. Galactosylated multimodular lipoplexes for specific gene transfer into primary hepatocytes.
Letrou-Bonneval E; Chèvre R; Lambert O; Costet P; André C; Tellier C; Pitard B
J Gene Med; 2008 Nov; 10(11):1198-209. PubMed ID: 18816485
[TBL] [Abstract][Full Text] [Related]
6. Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting.
Jiang HL; Kwon JT; Kim EM; Kim YK; Arote R; Jere D; Jeong HJ; Jang MK; Nah JW; Xu CX; Park IK; Cho MH; Cho CS
J Control Release; 2008 Oct; 131(2):150-7. PubMed ID: 18706946
[TBL] [Abstract][Full Text] [Related]
7. Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation.
Fumoto S; Kawakami S; Ito Y; Shigeta K; Yamashita F; Hashida M
Mol Ther; 2004 Oct; 10(4):719-29. PubMed ID: 15451456
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone (T3)-modification of polyethyleneglycol (PEG)-polyethyleneimine (PEI) graft copolymers for improved gene delivery to hepatocytes.
Rudolph C; Sieverling N; Schillinger U; Lesina E; Plank C; Thünemann AF; Schönberger H; Rosenecker J
Biomaterials; 2007 Apr; 28(10):1900-11. PubMed ID: 17196251
[TBL] [Abstract][Full Text] [Related]
9. Targeted gene delivery to hepatocytes with galactosylated amphiphilic cyclodextrins.
McMahon A; O'Neill MJ; Gomez E; Donohue R; Forde D; Darcy R; O'Driscoll CM
J Pharm Pharmacol; 2012 Aug; 64(8):1063-73. PubMed ID: 22775209
[TBL] [Abstract][Full Text] [Related]
10. Treatment efficacy of DNA lipid nanocapsules and DNA multimodular systems after systemic administration in a human glioma model.
David S; Montier T; Carmoy N; Resnier P; Clavreul A; Mével M; Pitard B; Benoit JP; Passirani C
J Gene Med; 2012 Dec; 14(12):769-75. PubMed ID: 23143656
[TBL] [Abstract][Full Text] [Related]
11. Galactosylated polyethylenimine-graft-poly(vinyl pyrrolidone) as a hepatocyte-targeting gene carrier.
Cook SE; Park IK; Kim EM; Jeong HJ; Park TG; Choi YJ; Akaike T; Cho CS
J Control Release; 2005 Jun; 105(1-2):151-63. PubMed ID: 15878633
[TBL] [Abstract][Full Text] [Related]
12. High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA.
Fujita T; Furuhata M; Hattori Y; Kawakami H; Toma K; Maitani Y
J Control Release; 2008 Jul; 129(2):124-7. PubMed ID: 18513820
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of poly(amidoamine) dendron-bearing lipids with poly(ethylene glycol) grafts and their use for stabilization of nonviral gene vectors.
Takahashi T; Hirose J; Kojima C; Harada A; Kono K
Bioconjug Chem; 2007; 18(4):1163-9. PubMed ID: 17569497
[TBL] [Abstract][Full Text] [Related]
14. A new triantennary galactose-targeted PEGylated gene carrier, characterization of its complex with DNA, and transfection of hepatoma cells.
Frisch B; Carrière M; Largeau C; Mathey F; Masson C; Schuber F; Scherman D; Escriou V
Bioconjug Chem; 2004; 15(4):754-64. PubMed ID: 15264862
[TBL] [Abstract][Full Text] [Related]
15. Poly(cationic lipid)-mediated in vivo gene delivery to mouse liver.
Liu L; Zern MA; Lizarzaburu ME; Nantz MH; Wu J
Gene Ther; 2003 Jan; 10(2):180-7. PubMed ID: 12571647
[TBL] [Abstract][Full Text] [Related]
16. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
Kim TH; Park IK; Nah JW; Choi YJ; Cho CS
Biomaterials; 2004 Aug; 25(17):3783-92. PubMed ID: 15020154
[TBL] [Abstract][Full Text] [Related]
17. Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes.
Bettinger T; Remy JS; Erbacher P
Bioconjug Chem; 1999; 10(4):558-61. PubMed ID: 10411451
[TBL] [Abstract][Full Text] [Related]
18. Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma.
Resnier P; LeQuinio P; Lautram N; André E; Gaillard C; Bastiat G; Benoit JP; Passirani C
Biotechnol J; 2014 Nov; 9(11):1389-401. PubMed ID: 25262914
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system.
Nishikawa M; Yamauchi M; Morimoto K; Ishida E; Takakura Y; Hashida M
Gene Ther; 2000 Apr; 7(7):548-55. PubMed ID: 10819569
[TBL] [Abstract][Full Text] [Related]
20. siRNA LNCs--a novel platform of lipid nanocapsules for systemic siRNA administration.
David S; Resnier P; Guillot A; Pitard B; Benoit JP; Passirani C
Eur J Pharm Biopharm; 2012 Jun; 81(2):448-52. PubMed ID: 22381204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
